Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» obesity
obesity
Lilly steps up its oral obesity push
EP Vantage
Thu, 05/25/23 - 08:45 pm
Eli Lilly
obesity
GLP-1 agonist
orforglipron
Next-gen Lilly obesity drug slashes weight in Innovent study—but is it enough to rival Mounjaro?
Fierce Biotech
Fri, 05/12/23 - 11:41 am
Innovent
Eli Lilly
obesity
mazdutide
clinical trials
Zealand, Boehringer's drug meets main weight-loss goal in mid-stage trial
BioSpace
Wed, 05/10/23 - 10:21 am
Boehringer Ingelheim
Zealand Pharma
obesity
clinical trials
BI 456906
‘Robbing Peter to pay Paul’: Obesity experts debate risks of new weight loss drugs
Stat
Tue, 05/9/23 - 10:33 am
side effects
Ozempic
Wegovy
Mounjaro
Novo Nordisk
Eli Lilly
obesity
Amid high demand, Novo Nordisk temporarily throttles US supply of low-dose Wegovy
Fierce Pharma
Thu, 05/4/23 - 09:05 pm
Novo Nordisk
Wegovy
obesity
Quitting Lilly's obesity drug tirzepatide may be difficult for many patients, exec says
Fierce Pharma
Thu, 04/27/23 - 10:48 pm
Eli Lilly
obesity
tirzepatide
patients
Lilly drug Mounjaro succeeds in second weight loss study
BioPharma Dive
Thu, 04/27/23 - 11:43 am
Eli Lilly
obesity
Mounjaro
clinical trials
In heavyweight obesity fight, Eli Lilly launches Mounjaro head-to-head trial against Novo Nordisk's Wegovy
Fierce Pharma
Mon, 04/24/23 - 10:20 am
Eli Lilly
clinical trials
obesity
Mounjaro
Novo Nordisk
Wegovy
Novo’s latest deal targets cell therapy for diabetes, obesity
BioPharma Dive
Thu, 04/13/23 - 12:02 pm
Novo Nordisk
cell therapy
diabetes
obesity
Aspect Biosystems
Diabesity drugs and their free ‘contract sales force’
Medical Marketing and Media
Tue, 04/4/23 - 10:12 am
Novo Nordisk
Eli Lilly
diabetes
obesity
telehealth
social media
Mounjaro
Wegovy
Boehringer signals intent in obesity
EP Vantage
Thu, 03/30/23 - 10:05 am
Boehringer Ingelheim
Zealand Pharma
obesity
clinical trials
BI 456906
Viking sets ships toward phase 2 after obesity med passes early test
Fierce Biotech
Tue, 03/28/23 - 10:48 pm
Viking Therapeutics
obesity
clinical trials
VK2735
The Ozempic Obesity Battle Is Heating Up With Novo Scoring A Fresh Win
Investors Business Daily
Sun, 03/26/23 - 11:28 pm
Novo Nordisk
Ozempic
diabetes
obesity
Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy
CP Wire
Sun, 03/26/23 - 03:44 pm
PTC Therapeutics
Novartis
Zolgensma
SMA
Novo Nordisk
Ozempic
obesity
diabetes
Baxter
M&A
Celltrio
Thermo Fisher
Pfizer
Astellas
Xtandi
NIH
Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy
Sun, 03/26/23 - 03:36 pm
PTC Therapeutics
Novartis
Zolgensma
SMA
Novo Nordisk
Ozempic
obesity
diabetes
Baxter
M&A
Celltrio
Thermo Fisher
Pfizer
Astellas
Xtandi
NIH
Altimmune's obesity drug throws up safety concerns, shares plunge
Yahoo/Reuters
Tue, 03/21/23 - 10:10 am
Altimmune
obesity
clinical trials
Covering new weight loss drugs could strain Medicare, policy experts warn
Stat
Sun, 03/12/23 - 09:54 pm
obesity
Medicare
Wegovy
Novo Nordisk
Altimmune aims to build Momentum in obesity
EP Vantage
Thu, 03/2/23 - 09:55 am
Altimmune
incretin pemvidutide
obesity
Eli Lilly's diabetes drug Mounjaro back in stock amid heightened obesity interest
Fierce Pharma
Wed, 02/22/23 - 06:51 pm
Eli Lilly
Mounjaro
diabetes
obesity
drug shortages
Novo Nordisk apologizes for not disclosing sponsorship of anti-obesity training
Financial Times
Mon, 02/13/23 - 10:44 am
Novo Nordisk
obesity
UK
Saxenda
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »